Abstract -The B12 biosynthetic pathway requires approximately 20 enzymes to convert aminolevulinic acid, methionine and cobalt to the comnoids. Recently several of the genes encoding the enzymes of B12 biosynthesis have been expressed in E. coli. The availability of these biosynthetic catalysts in large amounts has revolutionized the study of the B12 and heme pathways. Recent progress on the elucidation of the mechanism of several of these enzymes will be described. The technique of choice for these studies is high resolution NMR spectroscopy which can be used to detect intermediates in the catalytic cycle and to follow the overall reaction kinetics. Genetic engineering of the cDNA encoding for the biosynthetic enzymes has been used to study the mechanism of catalysis and to produce enzymes with altered substrate specificity in order to elucidate the mechanistic details of processes such as porphyrin assembly and C-methylation on the path to Biz.
INTRODUCTION
For the past 20 years our laboratory has been engaged in the elucidation of the vitamin B12 biosynthetic pathway and an earlier review1 described progress made in the fist ten years of this endeavor. By that time (1977), it had been established that 5-aminolevulinic acid (ALA), porphobilinogen (PBG) uro'gen I11 and the three partially methylated isobacteriochlorins, Factors I-III were the sequentially formed intermediates on the way to the comn nucleus exemplified by cobyrinic acid as summarized in Scheme 1. The ensuing decade has witnessed an exponential increase in the rate of the acquisition of pure enzymes using recombinant DNA techniques and these methods together with the exploration of new N M R pulse sequences have not only cast light on the mechanisms of Uro'gen 111 rvnthare the B12 synthetic enzymes but have given us considerable optimism with regard to the discovery of the remaining intermediates and of the enzymes which produce them. This lecture will focus on three topics drawn from the "early" and "late" segments of the pathway. The first of these deals with mechanistic and structural proposals for PBG deaminase, the assembly enzyme for tetrapyrrole biosynthesis which, working together with uro'gen I11 synthase, is responsible for the synthesis of the unsymmetrical type-111 macrocycle. The second topic encompasses the sequence of C-methylations connecting uro'gen I11 with the precomns, leading finally to cobyrinic acid and the properties of the purified methyl transferase responsible for the fist two methyl group insertions into uro'gen 111. Thirdly, the discovery of a new class of corphinoids, which reflect a degree of non-specificity of the B12 synthesizing enzymes and the consequences of this finding for the biochemical evolution of the B12 structure will be discussed. The complex problems inherent in tetrapyrrole and comn biosynthesis have occupied the attention of many laboratories over the last 20 years and although this article is concerned mainly with the author's contributions, key references to independent studies, notably from the laboratories of A. R. Battersby (Cambridge) G. Muller (Stuttgart) and P.M. Jordan (Southampton), which have provided valuable and stimulating results in the arena of heme and comn biosynthesis, will be found in the text.
THE E N Z Y M E S OF TETRAPYRROLE SYNTHESIS: PBG D E A M I N A S E A N D URO'GEN Ill SYNTHASE
PBG deaminase (EC4.3.1.8) catalyzes the tetramerization of PBG (1) to preuro'gen (hydroxymethylbilane, HMB; 2)293 which is cyclized with rearrangement to the unsymmetrical uro'gen I11 (3) by uro'gen I11 synthase39495 (EC4.2.1.75) (Scheme 1). In the absence of the latter enzyme, preuro'gen (2) cyclizes to uro'gen I (4), which, as discussed below, turns out to be a substrate for the methylases of the vitamin B12 pathway. We have used genetic engineering to construct a plasmid pBG 101 containing the Escherichia coli hemC gene697 for deaminase. E. coli (TBI) transformed with this plasmid produces deaminase at levels greater than 200 times those of the wild strain' thereby allowing access to substantial quantities of enzyme for detailed study of the catalytic mechanism. Previous work with deaminase 8-1 had established that a covalent bond is formed between substrate and enzyme, thus allowing isolation of covalent complexes containing up to 3 PBG units (ESl-ES3). Application of 3H-NMR spectroscopy to the mono PBG adduct (ES-1) revealed a rather broad 3H chemical shift indicative of covalent bond formation with a cysteine thiol group at the active site.12 However, with adequate supplies of pure enzyme available from the cloning of hemC we were able to show that a novel cofactor, derived from PBG during the biosynthesis of deaminase, is covalently attached to one of the four cysteine residues of the enzyme in the form of a dipyrromethane which, in turn, becomes the site of attachment of the succeeding four moles of substrate during the catalytic cycle.
Thus, at pH < 4, deaminase (5) rapidly develops a chromophore (hmax 485 nm) diagnostic of a pyrromethene (6), whilst reaction with Ehrlich's reagent generates a chromophore typical of a dipyrromethane (hmax 560 nm) changing to 490 nm after 5-10 min. The latter chromophoric interchange was identical with that of the Ehrlich reaction of the synthetic model pyrromethane (7) and can be ascribed to the isomerization shown (Scheme 2) for the model system (7). Incubation of E. coli strain SASX41B (transformed with plasmid pBG 101: hemA-requiring ALA for growth) with 5-13C-ALA afforded highly enriched enzyme for NMR studies. At pH8, the enriched carbons of the dipyrromethane (py-CH2-py) are clearly recognized at 24.0 ppm (py-CHzpy), 26.7 ppm (pyCHzX), 118.3 ppm (a-free pyrrole) and 129.7 ppm (a-substituted pyrrole) (Scheme 3). Comparison with synthetic models reveals that a shift of 26.7 ppm is in the range expected for an a-thiomethyl pyrrole (py-CH2 SR). Confirmation of the dipyrromethane (rather than oligo pyrromethane) came from the l3C INADEQUATE spectrum taken at pH12 which reveals the expected coupling only between py-CH2-py (8 24.7) and the adjacent substituted pyrrole carbon (8 128.5 ppm) . When the enriched deaminase was studied by INVERSE INEPT spectroscopy, each of the 5 protons attached to %nuclei were observed. A specimen of deaminase was covalently inhibited with the suicide inhibitor [2,11-13C2]-2-bromo PBG (8, Scheme 3) to give a CMR spectrum (pH12) consistent only with structure 9. The site of covalent attachment of substrate (and inhibitor) is therefore the free a-pyrrole carbon at the terminus of the dipyrromethane in the native enzyme, leading to the structural and mechanistic proposal for deaminase shown in Scheme 3. It was also possible to show that 2 moles of PBG are incorporated autocatalytically folding13 and that the first (kinetic) encounter of PBG deaminase with substrate involves attachment of PBG (with into the apoenzyme (obtained by cloning into an overexpression vector in E. coli which does not make PBG )bs;fQEe loss of NH3) to the a-free pyrrole position of the dipyrromethane to form the ES1 complexl4915 (Scheme 3). The process is repeated until the "tetra PBG' (ES4) adduct (10) is formed. At this juncture site-specific cleavage of the W I T 0 l g chain (at -+) releases the azafulvene bilane (11) which becomes the substrate of uro'gen I11 synthase, or in the absence of ,the latter enzyme, is stereospecifically hydrated3 to HMB (2) at pH12, or is cyclized chemically to uro'gen I (4) at pH 5 8. Independent, complementary work from two other laboratoriesl6~17 has reached similar conclusions regarding the catalytic site. The %labeling defines the number of PBG units (two) attached in a head-to-tail motif to the native enzyme at pH8 and reveals the identity of the nucleophilic group (Cys-SH) which anchors the dipyrromethane (and hence the growing oligopyrrolic chain) to the enzyme. Site specific mutagenesis7 and chemical cleavage16917918 were employed to determine that Cys-242 is the point of attachment of the cofactor. Thus, replacement7 of cysteine with serine at residues 99 and 242 (respectively) gave fully active and inactive specimens of the enzyme respectively. The use of the a-carbon of a dipyrromethane unit as the nucleophilic group responsible for oligomerization of 4 moles of PBG (with loss of NH3 at each successive encounter with an afree pyrrole) is not only remarkable for the exquisite specificity and control involved, but is, as far as we know, a process unique in the annals of enzymology in that a substrate is used not only once, but & in the genesis of the active site cofactor!. Even more remarkable is the fact that the apoenzyme is automatically transformed to the active holoenzyme by addition of two substrate PBG units without the intervention of a second enzyme. Crystallization and X-ray diffraction studies of both the native enzyme and several of its genetically altered versions are now in progress.
URO'GEN Ill SYNTHASE -T H E RING D SWITCH
We now turn briefly to the rearranging enzyme Uro'gen III synthase. With the acquisition of substantial quantities of pure Uro'gen 111 synthase obtained by cloning the genes hemC and D &gether19 and overexpression in E . coli, the substrate specificity of the synthase (often called cosynthetase) has been reinvestigated. Ever since its conception20 by Mathewson and Corwin in 1961, the spiro compound (13) (Scheme 3) has been a favorite construct with organic chemists, since both its genesis through a-pyrrolic reactivity and its fragmentationrecombination rationalize the intramolecular formation of Uro'gen 111 from the linear bilane, preuro'gen (HMB3). A careful search for the spiro-compound (13) was conducted at subzero temperatures in cryosolvent (-24' C; ethylene glycol/buffer) using various 1%-isotopomers of HMB as substrate.19 Although the synthase reaction could be slowed down to 20 hours (rather than 20 sec.) no signals corresponding to the quaternary carbon (6 -80 ppm or to the a-pyrrolic methylene groups (A; 6 35-40 ppm) could be observed. During these studies, however, it was found that Ah4B (12) served as a slow but productive substrate for Uro'gen 111 synthase 7
(1 m o l e in enzyme and substrate concentrations) and that if care is not taken to remove the ammonia liberated from PBG by the action of deaminase, not only is the enzymatic formation of AMB observed21*22 but in presence of Uro'gen I11 synthase, the product is again Uro'gen 111. This raises the interesting question of whether, under certain conditions, the true substrate for Uro'gen I11 synthase is in fact AMB formed at the locus of deaminase by the ammonia released from the substrate. Present research is directed towards the solution of this problem by more sensitive, low temperature spectroscopy.
TEMPORAL RESOLUTION OF THE METHYLATION SEQUENCE
The bioconversion of Uro'gen 111 to cobyrinic acid is summarized in Scheme. 1 where it is postulated that the e level as t -.
The lability of the reduced isobacteriochlorins, the fact that they are normally isolated in the oxidized form, and the requirement for chemical reduction of Factor I (but not Factors I1 and 111) before incorporation into comn in cell free systems lent credence to this idea but rigorous proof for the in vivo oxidation state of Factors I and I1 has only recently been obtained as discussed below.23~2~ In order to distinguish between the oxidation levels of the isolated chlorins, isobacteriochlorins, corphins, etc.. and to avoid possible confusion in using the term "Factor" (which has other connotations in B12 biochemistry e.g. intrinsic FactorFactor III) the term precomn-n has been suggestedu for the actual structures of the biosynthesized intermediates after Uro'gen III where n denotes the number of SAM derived methyl groups. Thus, although the names Factors I-Ill for the isolated species will probably survive(for historical reasons) all of the true intermediates probably have the same oxidation as Uro'gen I11 vir. tetrahydro Factor I (precorrin-1), dihydro Factor I1 (precorrin-2), and dihydro Factor I11 (precorrin-3) (Scheme 4). In spite of In order to justify the continuation of the search for such intermediates whose inherent lability to oxygen is predictable, 13C pulse labeling methods were applied to the cell-free system which converts Uro'gen I11 (3) to precomn-2 and thence to cobyrinic acid. By this approach it was possible to "read' the biochemical history of the methylation sequence as reflected in the dilution (or enhancement in the reverse experiment) of 13CH3 label in the methionine-derived methyl groups of cobyrinic acid after conversion to cobester, whose 1 3 C -M spectra has been assigned.29930 The pulse experiments defined the complete methylation sequence, beginning from precomn-2, as C-20 > C-17 > C-12a > C-1 > C-5 > C-15. Methylation at C-20 of precomn-2 to give precomn-3 is not recorded in the spectrum of cobester since C-20 is lost on the way to cobyrinic acid, together with the attached methyl group, in the form of acetic acid.25-28 The sequence C-17 > C-1 > C-12a has also been found in Clostridium tetunomorphumu and further differentiation between C-5 and C-15 insertion suggests the order C-15 > C-5 in this organism for the last two methylations, i.e. opposite from the P. shemunii sequence. A rationale for these events is given in Scheme 5, which takes the following facts into account: (a) the methionine derived methyl group at C-20 of precomn-3 does not migrate to C-1 and is expelled together with C-20 from a late intermediate (as yet unknown) in the form of acetic acid (b) neither 5,15-norcomnoids33 nor descobalto-cobyrinic acid34 are biochemical precursors of cobyrinic acid (c) regiospecific loss of l*O from [l-13C, 1-180&5-aminolevulinic acid-derived cyanocobalamin from the ring A acetate occurs,35 in accord with the concept of lactone formation, as portrayed in Scheme 5, where precorrin-5 is methylated at C-20 followed by C-20 + C-1 migration and lactonization. If the latter mechanism is operative, the C-20 + C-1 migration must be stereospecific, since precorrh-3 labeled at C-20 with 13CH3 is transformed to cobyrinic acid with complete loss of label, a less attractive alternative being direct methylation at C-1. It has also proved possible to define the point in the biosynthetic sequence where ring C-decarboxylation occurs, using synthetic [5,15-14C2]-12-decarboxylated uro'gen I11 (14) as a substrate for the non-specific methylases of P. shermanii to prepare the 12-methyl analogs (15) and (16) of factors I1 and III respectively (Scheme 6). Reduction and incubation of these possible intermediates with the comnsynthesizing cell-free system in the presence of SAM afforded (after esterification) samples of cobester whose specific activities were compared in a control experiment with those of cobester derived from [14C]-precomin-2 and from a mixture of [3H]-precomn-3 and [%]-precomn-2. It was f0und3~ that these ring C-decarboxylated analogs are a substrates for the enzymes of conin biosynthesis (Scheme 6), leading to the conclusions that (a) in normal biosynthesis, precomn-3 is the intermediate which is decarboxylated (b) decarboxylation occurs at some stage after the fourth methylation (at C-17) and by mechanistic analogy, before the fifth methylation at C-12. Hence, two pyrrocorphin intermediates viz. precomns 4a, 4b should intervene between precomns-3 and -5 i.e. precomn-3 is C-methylated at C-17 to give precomn-4a followed by decarboxylation (+ 4b) and subsequent C-methylations at C-l2a, C-1, (2-5, C-15, in that order as suggested in Scheme 5. Although the methylation sequence differs in the last two insertions from that reported for C. rerarwmorphum,~ consensus over the timing of decarboxylation in ring C has been reached since identical conclusions have been reported using Pseudomom denitrijicam.36.37 We now return to the construction of a working hypothesis for comn biosynthesis. The formulations precomns 6b, 7,8a, 8b take into account the idea of lactone formation using rings A and D acetate side chains. The migration C-20 + C-1 could be acid or metal ion catalyzed and the resultant C-20 carbonium ion quenched with external hydroxide or by the internal equivalent from the carboxylate anion of the C-2 acetate in ring A @recomn 8a + 8b) as suggested by the results of labeling with 180 discussed above.35 In any event, the resultant dihydrocorphinol-bislactone precomn-8b, is poised to undergo the biochemical counterpart of Eschenmoser ring contraction38 to the 19-acetyl comn. Before this happens we suggest that the final methyl groups are added at C-5 (precomn-7), then C-15 (precomn-la) to take account of the non-incorporation of the 5, 15-norcorrinoids.33 The resultant precomn3b (most probably with cobalt in place) then contracts to 19-acetyl comn which, by loss of acetic acid as an irreversible step involving a deuterium isotope effecf33~39-42 leads to cobyrinic acid. Cobalt insertion must precede methylation at Cs and Cis since hydrogenocobyrinic acid does not insert cobalt enzymaticallyM. The valency change Co++ + Co+++ during or after cobalt insertion has so far received no explanation. 
THE METHYL TRANSFEREASES
The first of the methylase enzymes catalyzes the sequential formation of Factors I and I1 and has been named Sadenosyl methionine Uro'gen III methyl transferase (SUMT). SUMT was first partidly purified from P. shermunii by G . Mulled3 and recently has been overexpressed in Pseudomonas denitrifcans.4 In E . coli it was found that the CysG gene encodes Uro'gen I11 methylase (M-I) as part of the synthetic pathway to siroheme, the cofactor for sulfite reductase, and overproduction was achieved by the appropriate genetic engineering45 Although, SUMT and M-1 appear to perform the same task, it has beeen found that their substrate specificities differ. Thus, it has been possible to study in detail the reaction catalyzed by M-1 directly using NMR spectroscopy and to provide rigorous proof that the structure of precorrin-2 is that of the dipyrrocorphin tautomer of dihydro-Factor I1 (dihydrosirohydrochlorin). Uro'gen I11 (enriched from [13C-5-ALA] at the positions shown in Scheme 7) was incubated with M-1 and [13CH3]-SAM. The resultant spectrum of the precomn-2 revealed an sp3 enriched carbon at C-15, thereby locating the reduced center. By using a different set of '3C-labels (0 from 13C-3 ALA) and [13CH3]-SAM) the sp2 carbons at C12 and c18 were located as well as the sp3 centers coupled to the pendant l3C-methyl groups at C2 and C7. This result confirms an earlier NMR analysis23 of precomn-2 isolated by anaerobic purification of the methyl ester, and shows that no further tautomerism takes place during the latter procedure. The two sets of experiments mutually reinforce the postulate that precorrins-1, -2, and -3 all exist as hexahydroporphinoids and recent labeling experiments46 have provided good evidence that precorrin-1 is discharged from the methylating enzyme (SUMT) as the species with the structure shown (or an isomer). However, prolonged incubation (2 hr.) of Uro'gen I11 with M-1 provided a surprising result for the UV and NMR changed dramatically from that of precomn-2 (a dipyrrocorphin) to the chromophore of a pyrrocorphin, hitherto only known only as a synthetic tautomer of hexahydroporphyrin. At first sight, this event seemed to signal a further tautomerism of a dipyrrocorphin to a pyrrocorphin catalyzed by the enzyme but when lJCH3-SAM was added to the incubation, it was found that a methyl group signal appeared in the 19-21 ppm region of the N M R spectrum.
When Uro'gen 111 was provided with the 13C labels ( 0 ) (as shown in Scheme 7) 3 pairs of doublets appeared in the sp3 region (6 50-55 ppm) of the pyrrocorphin product. The necessary pulse labeling experiments together with appropriate FAB-MS data finally led to the structural proposal (17)47148 for the novel trimethyl pyrrocorphin produced by "overmethylation" of the normal substrate, uro'gen 111, in presence of high concentration of enzyme. Thus M-1 has been recruited to insert a ring C methyl and synthesizes the long sought "natural" chromophore corresponding to that of the postulated preconin-4 although in this case the regiospecificity is altered from ring D to ring C. This lack of specificity on the part of M-1 was further exploited to synthesize a range of "unnatural"
isobacteriochlorins and pyrrocorphins based on isomers of Uro'gen 111. Thus, Uro'gen I produces 3 methylated products corresponding to preconin I, precomn-2 (18), and the type-I pyrrocorphin (19) (Scheme 8). Uro'gens I1
and IV can also serve as substrates for M-1 but not for SUMT! These compounds are reminiscent of a series of tetramethyl type I corphinoids, Factors S1-S4 isolated from P . shermnii49*50 which occur as their zinc complexes. When uro'gen I was incubated with SUMT,51 isolation of Factor I1 of the type I (Sirohydrochlorin I) family revealed a lack of specificity for this methyltransferase also, although in the latter studies no pyrrocorphins were observed. This may reflect a control mechanism in the P . denitrificans enzyme (SUMT) which does not "overmethylate" precomn-2 zs is found for the E. coli M-1 whose physiological function is to manufacture sirohydrochlorin. The fact that E. coli does not synthesize B12 could reflect an evolutionary process in which the C-methylation machinery has been retained, but is only required to insert the C-2 and C-7 methyl groups. The sites of C-methylation in both the type I and I11 series are also reminiscent of the biomimetic C-methylation of the hexahydroporphynns discovered by Eschenmoser52 and the regiospecificity is in accord with the principles adumbrated53 for the stabilizing effect of a vinylogous ketimine system. In principle the methylases of the B12 pathway, which synthesize both natural and unnatural pyrrocorphins and corphins can be harnessed to prepare several of the missing intermediates of the biosynthetic pathway, e.g. (20) + (21) (Scheme 8). It is of note that the instability towards oxygen rationalizes OUT earlier inability to isolate any new intermediates under aerobic conditions (> 5 ppm 02).
EVOLUTIONARY ASPECTS AND FURTHER OUTLOOK
Genetic mapping of the loci of the B 12-synthesizing enzymes has been reported for Pseudomows denitrifcans.4 This complements a most interesting study on the genetics of Salmonella typhimurium which cannot make B12 when grown aer0bically.5~ A mutant requiring methionine, cobinamide or cyanocobalamin when grown anaerobically produces B12 de novo thus leading to the isolation of other mutants blocked in B12 synthesis including one which cannot make Factor I1 required for siroheme production. All of the cobalamin mutations lie close together on the chromosome and a cluster of several methyl transferases maps at 42 min. Thus rapid progress can be expected in the isolation of the remaining biosynthetic enzymes from Salmonella. Until quite recently it had been assumed that the Shemin pathway (glycine-succinate) to ALA was ubiquitous in bacterial production of porphyrins and conins. However it is now clear that in many archaebacteria (e.g. Methanobacterium thermoautotrophicum,~~ Clostridium thermoaceticum56-S7) the C5 pathway from glutamate is followed. Phylogenetically the C5 route is conserved in higher plants, and it appears from recent work58 that hemA of E. coli (and perhaps of S. ryphimurium) encodes the enzyme for the glutamate + ALA conversion, i.e. the C5 pathway is much more common than had been realized. In C. thermoaceticum we have shown57 that the B12 produced by this thermophilic archaebacterium is synthesized from ALA produced from glutamate. Although E. coli does not seem to be able to synthesize B12, the enzyme M-1, a close relative of SUMT, is expressed as part of the genetic machinery (CysG) for making siroheme, as discussed above. Eschenmoser has speculated that corrinoids resembling B12 could have arisen by prebiotic polymerization of hydrogen cyanide and has developed an impressive array of chemical models53 to support this hypothesis, including ring contraction of porphyrinoids to acetyl comns, deacetylation and the C-methylation chemistry discussed earlier, which provide working hypotheses for the corresponding biochemical sequences. A primitive form of comn stabilized by hydrogen,53 rather than by methyl substitution may indeed have existed > 4 x 109 years ago, before the origin of life59 or the genetic code60 and could have formed the original "imprint" necessary for the evolution of enzymes which later mediated the insertion of methyl groups to provide a more robust form of B12. Since B12 is found in primitive anaerobes and requires no oxidative process in its biogenesis (unlike the routes to heme and chlorophyll which are oxidative) an approximate dating of B12 synthesis would be 2.7 -3.5 x 109 years, i.e. after DNA but before oxygen-requiring metabolism.61 With the genetic mapping of B12 biosynthesis now under way, it should at last be possible to discover the remaining intermediates beyond-precomn-3, together with the enzymes which mediate the methyl transfers, decarboxylation, ring contraction, deacetylation, and cobalt insertion. It is anticipated that the powerful combination of molecular biology and NMR spectroscopy which has been essential in solving the problems in B12 synthesis posed by the assembly and intermediacy of Uro'gen I11 and the subsequent C-methylations leading to precomn-3, will again be vital to the solution of those enigmas still to be unraveled in the fascinating saga of B12 biosynthesis. 
